Tepper Mark 4
4 · Corbus Pharmaceuticals Holdings, Inc. · Filed Nov 16, 2018
Insider Transaction Report
Form 4
Tepper Mark
President and CSO
Transactions
- Exercise/Conversion
Common Stock
2018-11-14$1.00/sh+10,000$10,000→ 2,110,400 total - Exercise/Conversion
Option to purchase common stock
2018-11-14−10,000→ 261,600 totalExercise: $1.00From: 2015-04-11Exp: 2024-04-11→ Common Stock (10,000 underlying)